Literature DB >> 17360752

Physical and functional interactions of human endogenous retrovirus proteins Np9 and rec with the promyelocytic leukemia zinc finger protein.

Miriam Denne1, Marlies Sauter, Vivienne Armbruester, Jonathan D Licht, Klaus Roemer, Nikolaus Mueller-Lantzsch.   

Abstract

Only few of the human endogenous retrovirus (HERV) sequences in the human genome can produce proteins. We have previously reported that (i) patients with germ cell tumors often make antibodies against proteins encoded by HERV-K elements, (ii) expression of the HERV-K rec gene in transgenic mice can interfere with germ cell development and induce carcinoma in situ, and (iii) HERV-K np9 transcript is overproduced in many tumors including breast cancers. Here we document that both Np9 and Rec physically and functionally interact with the promyelocytic leukemia zinc finger (PLZF) tumor suppressor, a transcriptional repressor and chromatin remodeler implicated in cancer and the self-renewal of spermatogonial stem cells. Interaction is mediated via two different central and C-terminal domains of Np9 and Rec and the C-terminal zinc fingers of PLZF. One major target of PLZF is the c-myc proto-oncogene. Coexpression of Np9 and Rec with PLZF abrogates the transcriptional repression of the c-myc gene promoter by PLZF and results in c-Myc overproduction, altered expression of c-Myc-regulated genes, and corresponding effects on cell proliferation and survival. Thus, the human endogenous retrovirus proteins Np9 and Rec may act oncogenically by derepressing c-myc through the inhibition of PLZF.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17360752      PMCID: PMC1900259          DOI: 10.1128/JVI.02771-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  43 in total

1.  Initial sequencing and analysis of the human genome.

Authors:  E S Lander; L M Linton; B Birren; C Nusbaum; M C Zody; J Baldwin; K Devon; K Dewar; M Doyle; W FitzHugh; R Funke; D Gage; K Harris; A Heaford; J Howland; L Kann; J Lehoczky; R LeVine; P McEwan; K McKernan; J Meldrim; J P Mesirov; C Miranda; W Morris; J Naylor; C Raymond; M Rosetti; R Santos; A Sheridan; C Sougnez; Y Stange-Thomann; N Stojanovic; A Subramanian; D Wyman; J Rogers; J Sulston; R Ainscough; S Beck; D Bentley; J Burton; C Clee; N Carter; A Coulson; R Deadman; P Deloukas; A Dunham; I Dunham; R Durbin; L French; D Grafham; S Gregory; T Hubbard; S Humphray; A Hunt; M Jones; C Lloyd; A McMurray; L Matthews; S Mercer; S Milne; J C Mullikin; A Mungall; R Plumb; M Ross; R Shownkeen; S Sims; R H Waterston; R K Wilson; L W Hillier; J D McPherson; M A Marra; E R Mardis; L A Fulton; A T Chinwalla; K H Pepin; W R Gish; S L Chissoe; M C Wendl; K D Delehaunty; T L Miner; A Delehaunty; J B Kramer; L L Cook; R S Fulton; D L Johnson; P J Minx; S W Clifton; T Hawkins; E Branscomb; P Predki; P Richardson; S Wenning; T Slezak; N Doggett; J F Cheng; A Olsen; S Lucas; C Elkin; E Uberbacher; M Frazier; R A Gibbs; D M Muzny; S E Scherer; J B Bouck; E J Sodergren; K C Worley; C M Rives; J H Gorrell; M L Metzker; S L Naylor; R S Kucherlapati; D L Nelson; G M Weinstock; Y Sakaki; A Fujiyama; M Hattori; T Yada; A Toyoda; T Itoh; C Kawagoe; H Watanabe; Y Totoki; T Taylor; J Weissenbach; R Heilig; W Saurin; F Artiguenave; P Brottier; T Bruls; E Pelletier; C Robert; P Wincker; D R Smith; L Doucette-Stamm; M Rubenfield; K Weinstock; H M Lee; J Dubois; A Rosenthal; M Platzer; G Nyakatura; S Taudien; A Rump; H Yang; J Yu; J Wang; G Huang; J Gu; L Hood; L Rowen; A Madan; S Qin; R W Davis; N A Federspiel; A P Abola; M J Proctor; R M Myers; J Schmutz; M Dickson; J Grimwood; D R Cox; M V Olson; R Kaul; C Raymond; N Shimizu; K Kawasaki; S Minoshima; G A Evans; M Athanasiou; R Schultz; B A Roe; F Chen; H Pan; J Ramser; H Lehrach; R Reinhardt; W R McCombie; M de la Bastide; N Dedhia; H Blöcker; K Hornischer; G Nordsiek; R Agarwala; L Aravind; J A Bailey; A Bateman; S Batzoglou; E Birney; P Bork; D G Brown; C B Burge; L Cerutti; H C Chen; D Church; M Clamp; R R Copley; T Doerks; S R Eddy; E E Eichler; T S Furey; J Galagan; J G Gilbert; C Harmon; Y Hayashizaki; D Haussler; H Hermjakob; K Hokamp; W Jang; L S Johnson; T A Jones; S Kasif; A Kaspryzk; S Kennedy; W J Kent; P Kitts; E V Koonin; I Korf; D Kulp; D Lancet; T M Lowe; A McLysaght; T Mikkelsen; J V Moran; N Mulder; V J Pollara; C P Ponting; G Schuler; J Schultz; G Slater; A F Smit; E Stupka; J Szustakowki; D Thierry-Mieg; J Thierry-Mieg; L Wagner; J Wallis; R Wheeler; A Williams; Y I Wolf; K H Wolfe; S P Yang; R F Yeh; F Collins; M S Guyer; J Peterson; A Felsenfeld; K A Wetterstrand; A Patrinos; M J Morgan; P de Jong; J J Catanese; K Osoegawa; H Shizuya; S Choi; Y J Chen; J Szustakowki
Journal:  Nature       Date:  2001-02-15       Impact factor: 49.962

2.  An ancient family of human endogenous retroviruses encodes a functional homolog of the HIV-1 Rev protein.

Authors:  J Yang; H P Bogerd; S Peng; H Wiegand; R Truant; B R Cullen
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-09       Impact factor: 11.205

3.  Plzf regulates limb and axial skeletal patterning.

Authors:  M Barna; N Hawe; L Niswander; P P Pandolfi
Journal:  Nat Genet       Date:  2000-06       Impact factor: 38.330

4.  Dysfunction of the mitotic:meiotic switch as a potential cause of neoplastic conversion of primordial germ cells.

Authors:  D J B Adamah; P J Gokhale; D J Eastwood; E Rajpert De-Meyts; J Goepel; J R Walsh; H D Moore; P W Andrews
Journal:  Int J Androl       Date:  2006-02

5.  Expression of a human endogenous retrovirus, HERV-K, in the blood cells of leukemia patients.

Authors:  S Depil; C Roche; P Dussart; L Prin
Journal:  Leukemia       Date:  2002-02       Impact factor: 11.528

Review 6.  Notch signaling in mammary gland tumorigenesis.

Authors:  R Callahan; A Raafat
Journal:  J Mammary Gland Biol Neoplasia       Date:  2001-01       Impact factor: 2.673

7.  Human endogenous retrovirus protein cORF supports cell transformation and associates with the promyelocytic leukemia zinc finger protein.

Authors:  A Boese; M Sauter; U Galli; B Best; H Herbst; J Mayer; E Kremmer; K Roemer; N Mueller-Lantzsch
Journal:  Oncogene       Date:  2000-09-07       Impact factor: 9.867

8.  c-Myc can induce DNA damage, increase reactive oxygen species, and mitigate p53 function: a mechanism for oncogene-induced genetic instability.

Authors:  Omid Vafa; Mark Wade; Suzanne Kern; Michelle Beeche; Tej K Pandita; Garret M Hampton; Geoffrey M Wahl
Journal:  Mol Cell       Date:  2002-05       Impact factor: 17.970

9.  Requirement of Notch 1 and its ligand jagged 2 expressions for spermatogenesis in rat and human testes.

Authors:  T Hayashi; Y Kageyama; K Ishizaka; G Xia; K Kihara; H Oshima
Journal:  J Androl       Date:  2001 Nov-Dec

Review 10.  Translocations of the RARalpha gene in acute promyelocytic leukemia.

Authors:  A Zelent; F Guidez; A Melnick; S Waxman; J D Licht
Journal:  Oncogene       Date:  2001-10-29       Impact factor: 9.867

View more
  58 in total

1.  Expression of human endogenous retrovirus type K (HML-2) is activated by the Tat protein of HIV-1.

Authors:  Marta J Gonzalez-Hernandez; Michael D Swanson; Rafael Contreras-Galindo; Sarah Cookinham; Steven R King; Richard J Noel; Mark H Kaplan; David M Markovitz
Journal:  J Virol       Date:  2012-05-16       Impact factor: 5.103

Review 2.  An alternative approach to medical genetics based on modern evolutionary biology. Part 4: HERVs in cancer.

Authors:  Frank P Ryan
Journal:  J R Soc Med       Date:  2009-11       Impact factor: 5.344

3.  Understanding PLZF: two transcriptional targets, REDD1 and smooth muscle α-actin, define new questions in growth control, senescence, self-renewal and tumor suppression.

Authors:  Marina Kolesnichenko; Peter K Vogt
Journal:  Cell Cycle       Date:  2011-03-01       Impact factor: 4.534

4.  HIV-1 Rev interacts with HERV-K RcREs present in the human genome and promotes export of unspliced HERV-K proviral RNA.

Authors:  Laurie R Gray; Rachel E Jackson; Patrick E H Jackson; Stefan Bekiranov; David Rekosh; Marie-Louise Hammarskjöld
Journal:  Retrovirology       Date:  2019-12-16       Impact factor: 4.602

Review 5.  Human endogenous retrovirus-K (HML-2): a comprehensive review.

Authors:  Marta Garcia-Montojo; Tara Doucet-O'Hare; Lisa Henderson; Avindra Nath
Journal:  Crit Rev Microbiol       Date:  2018-10-14       Impact factor: 7.624

6.  Np9, a cellular protein of retroviral ancestry restricted to human, chimpanzee and gorilla, binds and regulates ubiquitin ligase MDM2.

Authors:  Kristina Heyne; Kathrin Kölsch; Marine Bruand; Elisabeth Kremmer; Friedrich A Grässer; Jens Mayer; Klaus Roemer
Journal:  Cell Cycle       Date:  2015-06-23       Impact factor: 4.534

7.  Betaretroviral envelope subunits are noncovalently associated and restricted to the mammalian class.

Authors:  Jamie E Henzy; John M Coffin
Journal:  J Virol       Date:  2012-12-05       Impact factor: 5.103

Review 8.  Viruses associated with human cancer.

Authors:  Margaret E McLaughlin-Drubin; Karl Munger
Journal:  Biochim Biophys Acta       Date:  2007-12-23

9.  Human endogenous retrovirus type K antibodies and mRNA as serum biomarkers of early-stage breast cancer.

Authors:  Feng Wang-Johanning; Ming Li; Francisco J Esteva; Kenneth R Hess; Bingnan Yin; Kiera Rycaj; Joshua B Plummer; Jeremy G Garza; Stefan Ambs; Gary L Johanning
Journal:  Int J Cancer       Date:  2013-09-13       Impact factor: 7.396

10.  Human endogenous retrovirus HERV-K(HML-2) encodes a stable signal peptide with biological properties distinct from Rec.

Authors:  Alessia Ruggieri; Esther Maldener; Marlies Sauter; Nikolaus Mueller-Lantzsch; Eckart Meese; Oliver T Fackler; Jens Mayer
Journal:  Retrovirology       Date:  2009-02-16       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.